Literature DB >> 17905964

Twentieth-century survival from osteosarcoma in childhood. Trends from 1933 to 2004.

L Foster1, G F Dall, R Reid, W H Wallace, D E Porter.   

Abstract

We have reviewed the data from our regional Bone Tumour Registry on patients with osteosarcoma diagnosed between 1933 and 2004 in order to investigate the relationship between survival and changes in treatment. There were 184 patients with non-metastatic appendicular osteosarcoma diagnosed at the age of 18 or under. Survival was calculated using Kaplan-Meier curves, and multivariate analysis was performed using the Cox regression proportional hazards model. The five-year survival improved from 21% between 1933 and 1959, to 62% between 1990 and 1999. During this time, a multi-disciplinary organisation was gradually developed to manage treatment. The most significant variable affecting outcome was the date of diagnosis, with trends in improved survival mirroring the introduction of increasingly effective chemotherapy. Our experience suggests that the guidelines of the National Institute for Clinical Excellence on the minimum throughput of centres for treatment should be enforced flexibly in those that can demonstrate that their historical and contemporary results are comparable to those published nationally and internationally.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17905964     DOI: 10.1302/0301-620X.89B9.19255

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  15 in total

1.  Prevalence of Metastasis at Diagnosis of Osteosarcoma: An International Comparison.

Authors:  Tracy A Marko; Brandon J Diessner; Logan G Spector
Journal:  Pediatr Blood Cancer       Date:  2016-02-29       Impact factor: 3.167

2.  Association of ITGA3 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma.

Authors:  Wu Yang; Maolin He; Jinmin Zhao; Zhe Wang
Journal:  Med Oncol       Date:  2014-01-01       Impact factor: 3.064

3.  COL1A1 polymorphism is associated with risks of osteosarcoma susceptibility and death.

Authors:  Maolin He; Zhe Wang; Jinmin Zhao; Yingbin Chen; Yang Wu
Journal:  Tumour Biol       Date:  2013-09-27

4.  Attenuated Salmonella typhimurium with IL-2 gene reduces pulmonary metastases in murine osteosarcoma.

Authors:  Brent S Sorenson; Kaysie L Banton; Natalie L Frykman; Arnold S Leonard; Daniel A Saltzman
Journal:  Clin Orthop Relat Res       Date:  2008-04-18       Impact factor: 4.176

Review 5.  Herpes simplex virus oncolytic therapy for pediatric malignancies.

Authors:  Gregory K Friedman; Joseph G Pressey; Alyssa T Reddy; James M Markert; G Yancey Gillespie
Journal:  Mol Ther       Date:  2009-04-14       Impact factor: 11.454

6.  [Biopsies from bone and soft tissue sarcoma : a nationwide survey in Germany].

Authors:  F Pohlig; U Lenze; F W Lenze; H Mühlhofer; J Schauwecker; H Rechl; R von Eisenhart-Rothe
Journal:  Orthopade       Date:  2013-11       Impact factor: 1.087

7.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

8.  Using epidemiology and genomics to understand osteosarcoma etiology.

Authors:  Sharon A Savage; Lisa Mirabello
Journal:  Sarcoma       Date:  2011-03-08

9.  Quantitative assessment of the association of COX-2 (Cyclooxygenase-2) immunoexpression with prognosis in human osteosarcoma: a meta-analysis.

Authors:  Zhe Wang; Maolin He; Zengming Xiao; Hao Wu; Yang Wu
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

10.  Association between GSTP1 polymorphisms and prognosis of osteosarcoma in patients treated with chemotherapy: a meta-analysis.

Authors:  Feifei Pu; Fengxia Chen; Songfeng Chen; Baichuan Wang; Jianxiang Liu; Zengwu Shao
Journal:  Onco Targets Ther       Date:  2015-07-23       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.